47.90
전일 마감가:
$48.49
열려 있는:
$48.54
하루 거래량:
391.25K
Relative Volume:
0.64
시가총액:
$1.77B
수익:
$154.15M
순이익/손실:
$-33.58M
주가수익비율:
-49.90
EPS:
-0.96
순현금흐름:
$-20.74M
1주 성능:
+2.39%
1개월 성능:
+6.99%
6개월 성능:
+38.64%
1년 성능:
+43.16%
Harrow Inc Stock (HROW) Company Profile
명칭
Harrow Inc
전화
615.733.4731
주소
1A BURTON HILLS BLVD, NASHVILLE, CA
HROW을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
HROW
Harrow Inc
|
47.90 | 1.80B | 154.15M | -33.58M | -20.74M | -0.96 |
|
ZTS
Zoetis Inc
|
124.65 | 55.21B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
16.16 | 51.59B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.83 | 43.51B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
31.76 | 37.11B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
UTHR
United Therapeutics Corp
|
464.93 | 20.32B | 3.08B | 1.24B | 1.07B | 25.61 |
Harrow Inc Stock (HROW) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-11 | 개시 | Cantor Fitzgerald | Overweight |
| 2025-06-12 | 개시 | BTIG Research | Buy |
| 2025-06-10 | 개시 | William Blair | Outperform |
| 2025-02-06 | 개시 | H.C. Wainwright | Buy |
| 2024-12-04 | 재확인 | B. Riley Securities | Buy |
| 2024-04-11 | 개시 | Craig Hallum | Buy |
| 2022-09-08 | 재개 | B. Riley Securities | Buy |
| 2021-10-14 | 재개 | B. Riley Securities | Buy |
| 2021-09-24 | 개시 | Aegis Capital | Buy |
| 2021-07-02 | 개시 | Ladenburg Thalmann | Buy |
모두보기
Harrow Inc 주식(HROW)의 최신 뉴스
Opaleye management sells $711,814 worth of Harrow shares - MSN
Harrow, Inc. (NASDAQ:HROW) Could Be Less Than A Year Away From Profitability - 富途牛牛
Here's What Could Help Harrow (HROW) Maintain Its Recent Price Strength - sharewise.com
Harrow, Inc. (HROW): A Bull Case Theory - Finviz
Zacks Research Upgrades Harrow (NASDAQ:HROW) to "Strong-Buy" - MarketBeat
Gap Down: Can Harrow Inc maintain sales growthBull Run & Safe Capital Allocation Plans - baoquankhu1.vn
Panic Selling: What are the future prospects of Harrow IncTrade Exit Summary & Real-Time Volume Analysis - baoquankhu1.vn
Harrow: Flirting With Missing 2025 Revised Guidance (NASDAQ:HROW) - Seeking Alpha
Value Recap: Will Harrow Inc benefit from geopolitical trendsWeekly Trend Summary & Weekly Momentum Stock Picks - baoquankhu1.vn
Responsive Playbooks and the HROW Inflection - Stock Traders Daily
Institution Moves: Is Harrow Inc stock attractive for ETFsTrade Analysis Summary & Low Drawdown Investment Strategies - moha.gov.vn
Harrow Stock (-8.3%): Major Holder Sale Near Highs Sparks Distribution - Trefis
Is Harrow Inc. stock a good choice for value investorsJuly 2025 Spike Watch & Technical Pattern Recognition Alerts - Улправда
Harrow (NASDAQ:HROW) Trading Down 6%Here's What Happened - MarketBeat
How Harrow Inc. stock compares to growth peers2025 Short Interest & Accurate Trade Setup Notifications - Улправда
Major Harrow Health Backer Quietly Unloads a Chunk of Shares - TipRanks
Why Harrow Inc. stock remains a top recommendationMarket Growth Summary & Daily Price Action Insights - Улправда
Will Harrow Inc. stock deliver shareholder value2025 Key Lessons & Daily Stock Momentum Reports - Улправда
Harrow Health stock hits 52-week high at 54.85 USD - Investing.com
Harrow Health stock hits 52-week high at 54.85 USD By Investing.com - Investing.com South Africa
Most Volatile Stocks in the US (January 2026) - Investing.com
Harrow, Inc. (HROW) Stock Analysis: Navigating a 28.88% Upside Potential Amidst Robust Revenue Growth - DirectorsTalk Interviews
Harrow (NASDAQ:HROW) Hits New 12-Month HighWhat's Next? - MarketBeat
Noteworthy Monday Option Activity: HROW, AR, FOUR - Nasdaq
HARROW INC (NASDAQ:HROW) Emerges as a High-Growth Momentum Stock with Strong Technical Setup - Chartmill
Calamos Advisors LLC Makes New $1.09 Million Investment in Harrow, Inc. $HROW - MarketBeat
Harrow (NASDAQ:HROW) Hits New 1-Year HighTime to Buy? - MarketBeat
Harrow Health stock hits 52-week high at 51.38 USD - Investing.com
Harrow Health stock hits 52-week high at 51.38 USD By Investing.com - Investing.com UK
Harrow, Inc. (NASDAQ:HROW) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Brookstone Capital Management Grows Stock Holdings in Harrow, Inc. $HROW - MarketBeat
Harrow, Inc. $HROW Shares Sold by Rice Hall James & Associates LLC - MarketBeat
Harrow (NASDAQ:HROW) Has A Somewhat Strained Balance Sheet - 富途牛牛
Squarepoint Ops LLC Has $640,000 Stock Holdings in Harrow, Inc. $HROW - MarketBeat
First Week of February 2026 Options Trading For Harrow (HROW) - Nasdaq
Is Harrow Inc. stock vulnerable to regulatory risksJuly 2025 PreEarnings & Daily Technical Stock Forecast Reports - bolumsonucanavari.com
Will Harrow Inc. stock gain from strong economyAnalyst Downgrade & Stepwise Trade Signal Guides - Улправда
What margin trends mean for Harrow Inc. stockQuarterly Portfolio Summary & Long-Term Capital Growth Strategies - DonanımHaber
Why Harrow Inc. stock appeals to dividend seekersJuly 2025 Intraday Action & Real-Time Volume Trigger Notifications - Улправда
Insider Buy: Can Harrow Inc. stock resist market sell offsRate Hike & Free Accurate Trade Setup Notifications - ulpravda.ru
Is Harrow Inc. stock attractive for income investorsMarket Performance Report & Consistent Growth Equity Picks - Улправда
CFO Boll Acquires 33,335 Of Harrow Inc [HROW] - TradingView — Track All Markets
Harrow (HROW) CEO Mark Baum exercises 180,000 stock options in company - Stock Titan
Harrow (NASDAQ:HROW) Trading Down 5.8%Should You Sell? - MarketBeat
Braidwell LP Trims Holdings in Harrow, Inc. $HROW - MarketBeat
Harrow (NASDAQ:HROW) Reaches New 52-Week HighWhat's Next? - MarketBeat
Harrow Health stock hits 52-week high at 50.75 USD - Investing.com
Harrow, Inc. $HROW Shares Bought by Marshall Wace LLP - MarketBeat
Precision Trading with Harrow Health Inc. 11.875% Senior Notes Due 2027 (HROWM) Risk Zones - Stock Traders Daily
Divisadero Street Capital Management LP Takes Position in Harrow, Inc. $HROW - MarketBeat
Aug Closing: Why Harrow Inc stock is favored by pension funds2025 Performance Recap & Daily Entry Point Trade Alerts - moha.gov.vn
Harrow Inc (HROW) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Harrow Inc 주식 (HROW) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| BOLL ANDREW R. | PRESIDENT AND CFO |
Dec 12 '25 |
Option Exercise |
3.95 |
60,000 |
237,000 |
837,844 |
| BAUM MARK L | CHIEF EXECUTIVE OFFICER |
Dec 12 '25 |
Option Exercise |
3.95 |
180,000 |
711,000 |
3,066,124 |
| BAUM MARK L | CHIEF EXECUTIVE OFFICER |
Jul 21 '25 |
Option Exercise |
7.87 |
600,000 |
4,722,000 |
3,199,462 |
| Opaleye Management Inc. | 10% Owner |
Jun 10 '25 |
Sale |
30.80 |
15,000 |
462,033 |
90,000 |
| Opaleye Management Inc. | 10% Owner |
Jun 09 '25 |
Sale |
30.37 |
15,204 |
461,794 |
105,000 |
| Opaleye Management Inc. | 10% Owner |
Jun 03 '25 |
Sale |
30.04 |
3,000 |
90,116 |
122,000 |
| Opaleye Management Inc. | 10% Owner |
Jun 04 '25 |
Sale |
30.02 |
1,796 |
53,907 |
120,204 |
| Opaleye Management Inc. | 10% Owner |
May 12 '25 |
Sale |
25.90 |
10,000 |
258,959 |
130,000 |
| Opaleye Management Inc. | 10% Owner |
May 13 '25 |
Sale |
26.59 |
5,000 |
132,945 |
125,000 |
| BOLL ANDREW R. | Chief Financial Officer |
Apr 03 '25 |
Option Exercise |
0.00 |
346,500 |
0 |
914,589 |
자본화:
|
볼륨(24시간):